| Title : Nicotinic Acetylcholine Receptor Modulation Distinguishes Clinical Benefits of Galantamine in Alzheimer's Disease - Svintozelskiy_2026_Sage.Open.Aging_12_30495334261485634 |
| Author(s) : Svintozelskiy PV , Wahlert AJ , Harrod C , Kay DG , Grady KP , Grossberg GT |
| Ref : Sage Open Aging , 12 :30495334261485634 , 2026 |
| Abstract : |
| PubMedSearch : Svintozelskiy_2026_Sage.Open.Aging_12_30495334261485634 |
| PubMedID: 42688663 |
| Title : Safety, pharmacokinetics, and pharmacodynamics of Gln-1062, a prodrug of galantamine - Bakker_2020_Alzheimers.Dement.(N.Y)_6_e12093 |
| Author(s) : Bakker C , van der Aart J , Hart EP , Klaassen ES , Bergmann KR , van Esdonk MJ , Kay DG , Groeneveld GJ |
| Ref : Alzheimers Dement (N Y) , 6 :e12093 , 2020 |
| Abstract : |
| PubMedSearch : Bakker_2020_Alzheimers.Dement.(N.Y)_6_e12093 |
| PubMedID: 33083515 |
| Title : First in human study with a prodrug of galantamine: Improved benefit-risk ratio? - Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| Author(s) : Baakman AC , t Hart E , Kay DG , Stevens J , Klaassen ES , Maelicke A , Groeneveld GJ |
| Ref : Alzheimers Dement (N Y) , 2 :13 , 2016 |
| Abstract : |
| PubMedSearch : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| PubMedID: 29067291 |